{
  "source": "PubMed",
  "query": "secondary metabolites",
  "title": "Evaluation of Beauvericin's activity and mode of action against all life stages ofL. tropicafor cutaneous Leishmaniasis therapy.",
  "abstract": "Leishmaniasis, particularly its cutaneous form caused byLeishmania tropica, remains a significant global health concern due to the limitations of current treatments, including drug resistance, toxicity, and inconsistent efficacy. This study investigates the potential of Beauvericin (BEA), a fungal secondary metabolite, as an alternative antileishmanial agent.",
  "publication_date": "2025-06-10",
  "journal": "Frontiers in cellular and infection microbiology",
  "doi": "10.3389/fcimb.2025.1599766"
}